drugset
drugset / Trial / NCT00567866

Methamphetamine-Quetiapine Interactions in Humans

NCT00567866 ↗

Phase 0 Terminated 10 enrolled University of Arkansas
RandomizedSingle-groupDouble-blindTreatment

Summary

This study will test the ability of a medicine (Quetiapine) that is used to treat schizophrenia or bipolar disorder to reduce the effects of methamphetamine that make it difficult for users to stop using it. This study will test the ability of a medicine that is used to treat schizophrenia or bipolar disorder to reduce the effects of methamphetamine that make it difficult for users to stop using it. The investigator thinks quetiapine will lessen the effects of methamphetamine.

Timeline

Start
2008-01
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule 50 mg Oral
Subject Quetiapine Small molecule 100 mg Oral

Indications

methamphetamine dependence